Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
11,549,491
-
Total 13F shares
-
10,800
-
Share change
-
+800
-
Total reported value
-
$4,104
-
Price per share
-
$0.38
-
Number of holders
-
2
-
Value change
-
+$304
-
Number of buys
-
1
Institutional Holders of TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) as of Q1 2022
As of 31 Mar 2022,
TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,800 shares.
The largest 2 holders included
SILVERLAKE WEALTH MANAGEMENT LLC and Baron Financial Group, LLC.
This page lists
2
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.